StockData
Agenus Inc logo

Agenus Inc (AGEN) stock

AGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 3/30
$6.29−0.44 (-6.54%)

Close on Nov 16, 2026Market cap $283.18MP/E –Yield –

Agenus ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Agenus's ebitda for the twelve months ending Jun 30, 2026 was $40.93M. For fiscal 2025 it was -$10.17M. The highest annual figure on record is $32.54M in fiscal 2021.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$10.17M–
FY2024Dec 31, 2024-$107.13M–
FY2023Dec 31, 2023-$145.96M–
FY2022Dec 31, 2022-$172.48M-630.1%
FY2021Dec 31, 2021$32.54M–
FY2020Dec 31, 2020-$110.06M–
FY2019Dec 31, 2019-$63.48M–
FY2018Dec 31, 2018-$117.53M–
FY2017Dec 31, 2017-$97.80M–
FY2016Dec 31, 2016-$102.53M–
FY2015Dec 31, 2015-$78.74M–
FY2014Dec 31, 2014-$41.74M–
FY2013Dec 31, 2013-$24.39M–
FY2012Dec 31, 2012-$5.12M–
FY2011Dec 31, 2011-$16.83M–
FY2010Dec 31, 2010-$18.31M–
FY2009Dec 31, 2009-$23.57M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$11.81M–
Q1 FY2026Mar 31, 2026$15.64M–
Q4 FY2025Dec 31, 2025$15.00M–
Q3 FY2025Sep 30, 2025-$1.51M–
Q2 FY2025Jun 30, 2025-$13.54M–
Q1 FY2025Mar 31, 2025-$10.11M–
Q4 FY2024Dec 31, 2024-$22.64M-2363.6%
Q3 FY2024Sep 30, 2024-$28.16M–
Q2 FY2024Jun 30, 2024-$26.83M–
Q1 FY2024Mar 31, 2024-$29.51M–
Q4 FY2023Dec 31, 2023$1.00M–
Q3 FY2023Sep 30, 2023-$43.49M–
Q2 FY2023Jun 30, 2023-$51.69M–
Q1 FY2023Mar 31, 2023-$51.78M–
Q4 FY2022Dec 31, 2022-$55.87M–
Q3 FY2022Sep 30, 2022-$39.94M-121.1%
Q2 FY2022Jun 30, 2022-$42.88M–
Q1 FY2022Mar 31, 2022-$33.80M–
Q4 FY2021Dec 31, 2021-$52.37M–
Q3 FY2021Sep 30, 2021$189.22M–
Q2 FY2021Jun 30, 2021-$64.67M–
Q1 FY2021Mar 31, 2021-$39.64M–
Q4 FY2020Dec 31, 2020-$19.87M–
Q3 FY2020Sep 30, 2020-$32.94M–
Q2 FY2020Jun 30, 2020-$31.48M–
Q1 FY2020Mar 31, 2020-$25.76M-192.5%
Q4 FY2019Dec 31, 2019-$17.62M–
Q3 FY2019Sep 30, 2019-$34.25M–
Q2 FY2019Jun 30, 2019-$39.46M–
Q1 FY2019Mar 31, 2019$27.85M–
Q4 FY2018Dec 31, 2018-$37.88M–
Q3 FY2018Sep 30, 2018-$24.44M–
Q2 FY2018Jun 30, 2018-$15.02M–
Q1 FY2018Mar 31, 2018-$40.19M–
Q4 FY2017Dec 31, 2017-$28.55M–
Q3 FY2017Sep 30, 2017-$30.16M–
Q2 FY2017Jun 30, 2017-$27.36M–
Q1 FY2017Mar 31, 2017-$11.73M–
Q4 FY2016Dec 31, 2016-$18.39M–
Q3 FY2016Sep 30, 2016-$35.09M–

More Agenus figures

See a number that looks wrong?